Status:
COMPLETED
Efficacy of Percutaneous SPG Block in Aneurysmal SAH
Lead Sponsor:
Mayo Clinic
Conditions:
Subarachnoid Hemorrhage
Headache
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Researchers are trying to develop alternative means to help patients with headache pain secondary to aneurysmal subarachnoid hemorrhage (bleeding about the brain).
Detailed Description
This study is an open label, feasibility study that will consist of fifteen patients. This study will enroll only patients who have aneurysmal SAH that are secured by endovascular coiling. When a pati...
Eligibility Criteria
Inclusion
- Age 18 and older
- Aneurysmal SAH in anterior/middle cerebral compartment
- Aneurysm must be secured endovascular with coiling
- The patient or patient's surrogate should be able to give informed consent and understand the risks of this study
- Pain NRS ≥ 5/10 in severity
Exclusion
- Non aneurysmal, traumatic SAH
- Posterior fossa aneurysm ruptures
- Pregnancy
- Transcranial Doppler velocities suggestive of or approaching vasospasm
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 8 2024
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT04331938
Start Date
November 1 2020
End Date
April 8 2024
Last Update
April 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905